Selected research
Industry Research
Morning-after Pill Industry Research Report 2026
Market perspective
The global Morning-after Pill market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Morning-after Pill is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Morning-after Pill is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Morning-after Pill is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Morning-after Pill include Zizhu Pharma, Zhejiang Xianju Pharma, Syzygy Healthcare, Regenex, Piramal, Mankind Pharma, Lupin, HRA Pharma and HLL Life Care, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Morning-after Pill market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Morning-after Pill Market by Company
Zizhu Pharma
Zhejiang Xianju Pharma
Syzygy Healthcare
Regenex
Piramal
Mankind Pharma
Lupin
HRA Pharma
HLL Life Care
Gedeon Richter
Foundation Consumer Healthcare
Morning-after Pill Segment by Type
Levonorgestrel
Ulipristal Acetate
Morning-after Pill Segment by Application
Online
Offline
Morning-after Pill Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morning-after Pill market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Morning-after Pill and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morning-after Pill.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Morning-after Pill manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Morning-after Pill by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Morning-after Pill in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Levonorgestrel
- Ulipristal Acetate
Applications
- Online
- Offline
Companies covered
- Zizhu Pharma
- Zhejiang Xianju Pharma
- Syzygy Healthcare
- Regenex
- Piramal
- Mankind Pharma
- Lupin
- HRA Pharma
- HLL Life Care
- Gedeon Richter
- Foundation Consumer Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Morning-after Pill Market Size (2021-2032)
- 2.2.2 Global Morning-after Pill Sales (2021-2032)
- 2.2.3 Global Morning-after Pill Market Average Price (2021-2032)
- 2.3 Morning-after Pill by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Levonorgestrel
- 2.3.3 Ulipristal Acetate
- 2.4 Morning-after Pill by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online
- 2.4.3 Offline
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Morning-after Pill Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Morning-after Pill Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Morning-after Pill Revenue of Manufacturers (2021-2026)
- 3.4 Global Morning-after Pill Average Price by Manufacturers (2021-2026)
- 3.5 Global Morning-after Pill Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Morning-after Pill, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Morning-after Pill, Product Type & Application
- 3.8 Global Manufacturers of Morning-after Pill, Established Date
- 3.9 Global Morning-after Pill Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zizhu Pharma
- 4.1.1 Zizhu Pharma Company Information
- 4.1.2 Zizhu Pharma Business Overview
- 4.1.3 Zizhu Pharma Morning-after Pill Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zizhu Pharma Morning-after Pill Product Portfolio
- 4.1.5 Zizhu Pharma Recent Developments
- 4.2 Zhejiang Xianju Pharma
- 4.2.1 Zhejiang Xianju Pharma Company Information
- 4.2.2 Zhejiang Xianju Pharma Business Overview
- 4.2.3 Zhejiang Xianju Pharma Morning-after Pill Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zhejiang Xianju Pharma Morning-after Pill Product Portfolio
- 4.2.5 Zhejiang Xianju Pharma Recent Developments
- 4.3 Syzygy Healthcare
- 4.3.1 Syzygy Healthcare Company Information
- 4.3.2 Syzygy Healthcare Business Overview
- 4.3.3 Syzygy Healthcare Morning-after Pill Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Syzygy Healthcare Morning-after Pill Product Portfolio
- 4.3.5 Syzygy Healthcare Recent Developments
- 4.4 Regenex
- 4.4.1 Regenex Company Information
- 4.4.2 Regenex Business Overview
- 4.4.3 Regenex Morning-after Pill Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Regenex Morning-after Pill Product Portfolio
- 4.4.5 Regenex Recent Developments
- 4.5 Piramal
- 4.5.1 Piramal Company Information
- 4.5.2 Piramal Business Overview
- 4.5.3 Piramal Morning-after Pill Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Piramal Morning-after Pill Product Portfolio
- 4.5.5 Piramal Recent Developments
- 4.6 Mankind Pharma
- 4.6.1 Mankind Pharma Company Information
- 4.6.2 Mankind Pharma Business Overview
- 4.6.3 Mankind Pharma Morning-after Pill Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mankind Pharma Morning-after Pill Product Portfolio
- 4.6.5 Mankind Pharma Recent Developments
- 4.7 Lupin
- 4.7.1 Lupin Company Information
- 4.7.2 Lupin Business Overview
- 4.7.3 Lupin Morning-after Pill Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lupin Morning-after Pill Product Portfolio
- 4.7.5 Lupin Recent Developments
- 4.8 HRA Pharma
- 4.8.1 HRA Pharma Company Information
- 4.8.2 HRA Pharma Business Overview
- 4.8.3 HRA Pharma Morning-after Pill Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 HRA Pharma Morning-after Pill Product Portfolio
- 4.8.5 HRA Pharma Recent Developments
- 4.9 HLL Life Care
- 4.9.1 HLL Life Care Company Information
- 4.9.2 HLL Life Care Business Overview
- 4.9.3 HLL Life Care Morning-after Pill Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 HLL Life Care Morning-after Pill Product Portfolio
- 4.9.5 HLL Life Care Recent Developments
- 4.10 Gedeon Richter
- 4.10.1 Gedeon Richter Company Information
- 4.10.2 Gedeon Richter Business Overview
- 4.10.3 Gedeon Richter Morning-after Pill Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Gedeon Richter Morning-after Pill Product Portfolio
- 4.10.5 Gedeon Richter Recent Developments
- 4.11 Foundation Consumer Healthcare
- 4.11.1 Foundation Consumer Healthcare Company Information
- 4.11.2 Foundation Consumer Healthcare Business Overview
- 4.11.3 Foundation Consumer Healthcare Morning-after Pill Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Foundation Consumer Healthcare Morning-after Pill Product Portfolio
- 4.11.5 Foundation Consumer Healthcare Recent Developments
5 Global Morning-after Pill Market Scenario by Region
- 5.1 Global Morning-after Pill Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Morning-after Pill Sales by Region: 2021-2032
- 5.2.1 Global Morning-after Pill Sales by Region: 2021-2026
- 5.2.2 Global Morning-after Pill Sales by Region: 2027-2032
- 5.3 Global Morning-after Pill Revenue by Region: 2021-2032
- 5.3.1 Global Morning-after Pill Revenue by Region: 2021-2026
- 5.3.2 Global Morning-after Pill Revenue by Region: 2027-2032
- 5.4 North America Morning-after Pill Market Facts & Figures by Country
- 5.4.1 North America Morning-after Pill Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Morning-after Pill Sales by Country (2021-2032)
- 5.4.3 North America Morning-after Pill Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Morning-after Pill Market Facts & Figures by Country
- 5.5.1 Europe Morning-after Pill Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Morning-after Pill Sales by Country (2021-2032)
- 5.5.3 Europe Morning-after Pill Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Morning-after Pill Market Facts & Figures by Country
- 5.6.1 Asia Pacific Morning-after Pill Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Morning-after Pill Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Morning-after Pill Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Morning-after Pill Market Facts & Figures by Country
- 5.7.1 South America Morning-after Pill Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Morning-after Pill Sales by Country (2021-2032)
- 5.7.3 South America Morning-after Pill Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Morning-after Pill Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Morning-after Pill Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Morning-after Pill Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Morning-after Pill Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Morning-after Pill Sales by Type (2021-2032)
- 6.1.1 Global Morning-after Pill Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Morning-after Pill Sales Market Share by Type (2021-2032)
- 6.2 Global Morning-after Pill Revenue by Type (2021-2032)
- 6.2.1 Global Morning-after Pill Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Morning-after Pill Revenue Market Share by Type (2021-2032)
- 6.3 Global Morning-after Pill Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Morning-after Pill Sales by Application (2021-2032)
- 7.1.1 Global Morning-after Pill Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Morning-after Pill Sales Market Share by Application (2021-2032)
- 7.2 Global Morning-after Pill Revenue by Application (2021-2032)
- 7.2.1 Global Morning-after Pill Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Morning-after Pill Revenue Market Share by Application (2021-2032)
- 7.3 Global Morning-after Pill Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Morning-after Pill Value Chain Analysis
- 8.1.1 Morning-after Pill Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Morning-after Pill Production Mode & Process
- 8.2 Morning-after Pill Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Morning-after Pill Distributors
- 8.2.3 Morning-after Pill Customers
9 Global Morning-after Pill Analyzing Market Dynamics
- 9.1 Morning-after Pill Industry Trends
- 9.2 Morning-after Pill Industry Drivers
- 9.3 Morning-after Pill Industry Opportunities and Challenges
- 9.4 Morning-after Pill Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst